| run              | dataset                  | method                      | size | time   | accuracy   | f1        |
|------------------|--------------------------|-----------------------------|------|--------|------------|-----------|
| 2023_03_03_10_27 | PubMed                   | BertBaseUncased5E0523       | 250  | 3.6m   | 10.80%     | 54.08%    |
| 2023_03_03_10_27 | PubMed                   | SetfitMax500Batch16Epochs30 | 250  | 0.5m   | 1.40%      | 0.00%     |
| 2023_03_03_10_27 | PubMed                   | SetfitMax500Batch16Epochs20 | 250  | 0.4m   | 1.40%      | 0.00%     |
| 2023_03_03_10_27 | PubMed                   | MetadataExtractorMethod     | 250  | 32.2m  | 0.00%      | 6.84%     |
| 2023_03_03_10_27 | news_topics              | BertBaseUncased5E0523       | 250  | 3.5m   | 5.80%      | 5.06%     |
| 2023_03_03_11_21 | PubMed                   | BertBaseUncased5E0523       | 250  | 2.8m   | 11.60%     | 54.26%    |
| 2023_03_03_11_21 | PubMed                   | SetfitMax500Batch16Epochs30 | 250  | 65.5m  | 9.20%      | 64.75%    |
| 2023_03_03_11_21 | PubMed                   | SetfitMax500Batch16Epochs20 | 250  | 43.9m  | 9.40%      | 64.15%    |
| 2023_03_03_11_21 | news_topics              | BertBaseUncased5E0523       | 250  | 2.7m   | 5.80%      | 5.06%     |
| 2023_03_03_11_21 | news_topics              | SetfitMax500Batch16Epochs30 | 250  | 13.9m  | 8.80%      | 24.14%    |
| 2023_03_03_13_34 | PubMed                   | SetfitMax500Batch16Epochs15 | 250  | 33.0m  | 10.00%     | 64.45%    |
| 2023_03_03_13_34 | news_topics              | SetfitMax500Batch16Epochs15 | 250  | 7.1m   | 8.60%      | 24.26%    |
| 2023_03_03_13_34 | PlanInternational_themes | SetfitMax500Batch16Epochs15 | 250  | 20.9m  | 28.07%     | 61.41%    |
| 2023_03_03_13_34 | UPR_action               | SetfitMax500Batch16Epochs15 | 250  | 5.4m   | 82.80%     | 69.09%    |
| 2023_03_03_13_34 | UPR_issues               | SetfitMax500Batch16Epochs15 | 250  | 7.7m   | 32.80%     | 29.84%    |
| 2023_03_03_14_52 | PlanInternational_themes | BertBaseUncased5E0523       | 250  | 2.0m   | 1.75%      | 14.82%    |
| 2023_03_03_14_52 | UPR_action               | BertBaseUncased5E0523       | 250  | 2.7m   | 80.80%     | 67.56%    |
| 2023_03_03_14_52 | UPR_issues               | BertBaseUncased5E0523       | 250  | 2.7m   | 0.00%      | 0.00%     |
| 2023_03_03_15_09 | UPR_issues               | SetfitMax500Batch16E30I2    | 250  | 7.8m   | 34.60%     | 29.50%    |
| 2023_03_03_15_24 | UPR_issues               | SetfitMax500Batch16E60I2    | 250  | 16.1m  | 32.00%     | 28.32%    |
| 2023_03_05_16_47 | PubMed                   | SetfitMax500Batch4E15I2     | 250  | 14.7m  | 7.60%      | 63.26%    |
| 2023_03_05_17_06 | PubMed                   | SetfitMax500Batch4E15I2     | 250  | 15.2m  | 7.40%      | 62.33%    |
| 2023_03_05_17_06 | news_topics              | SetfitMax500Batch4E15I2     | 250  | 9.7m   | 9.60%      | 27.24%    |
| 2023_03_05_17_06 | PlanInternational_themes | SetfitMax500Batch4E15I2     | 250  | 11.1m  | 28.07%     | 66.82%    |
| 2023_03_05_17_06 | UPR_action               | SetfitMax500Batch4E15I2     | 250  | 6.9m   | 80.80%     | 67.12%    |
| 2023_03_05_17_06 | UPR_issues               | SetfitMax500Batch4E15I2     | 250  | 8.6m   | 42.60%     | 41.18%    |
| 2023_03_05_18_06 | PubMed                   | SetfitT250Batch2E15I2       | 250  | 50.5m  | 7.00%      | 61.75%    |
| 2023_03_05_18_06 | news_topics              | SetfitT250Batch2E15I2       | 250  | 16.6m  | 10.00%     | 27.13%    |
| 2023_03_05_18_06 | PlanInternational_themes | SetfitT250Batch2E15I2       | 250  | 16.1m  | 28.07%     | 65.79%    |
| 2023_03_05_18_06 | UPR_action               | SetfitT250Batch2E15I2       | 250  | 10.7m  | 81.80%     | 68.26%    |
| 2023_03_05_18_06 | UPR_issues               | SetfitT250Batch2E15I2       | 250  | 14.5m  | 46.40%     | 45.79%    |
| 2023_03_07_12_11 | PubMed                   | SetfitT250Batch2E15I1       | 250  | 25.7m  | 7.40%      | 63.26%    |
| 2023_03_07_12_11 | news_topics              | SetfitT250Batch2E15I1       | 250  | 9.2m   | 11.00%     | 25.43%    |
| 2023_03_07_12_11 | PlanInternational_themes | SetfitT250Batch2E15I1       | 250  | 8.9m   | 28.07%     | 65.27%    |
| 2023_03_07_12_11 | UPR_action               | SetfitT250Batch2E15I1       | 250  | 6.2m   | 82.80%     | 68.33%    |
| 2023_03_07_12_11 | UPR_issues               | SetfitT250Batch2E15I1       | 250  | 8.1m   | 48.00%     | 47.44%    |
| 2023_03_07_16_52 | PubMed                   | SetfitT250Batch8E10I1       | 5000 | 136.6m | 9.20%      | 69.47%    |
| 2023_03_07_16_52 | news_topics              | SetfitT250Batch8E10I1       | 5000 | 27.1m  | 11.00%     | 47.15%    |
| 2023_03_07_16_52 | PlanInternational_themes | SetfitT250Batch8E10I1       | 1029 | 13.2m  | 33.33%     | 76.17%    |
| 2023_03_07_16_52 | UPR_action               | SetfitT250Batch8E10I1       | 5000 | 10.9m  | 86.20%     | 86.73%    |
| 2023_03_08_10_08 | UPR_issues_balanced      | SetfitT250Batch8E10I1       | 5000 | 30.2m  | 67.00%     | 78.90%    |
| 2023_03_08_10_54 | PubMed                   | SetfitT250Batch8E15I1       | 5000 | 201.2m | 8.80%      | 69.69%    |
| 2023_03_08_10_54 | PubMed                   | SetfitT250Batch8E20I1       | 5000 | 278.5m | 10.40%     | 70.59%    |
| 2023_03_08_10_54 | news_topics              | SetfitT250Batch8E15I1       | 5000 | 40.1m  | 11.60%     | 48.10%    |
| 2023_03_08_10_54 | news_topics              | SetfitT250Batch8E20I1       | 5000 | 53.4m  | 12.40%     | 47.65%    |
| 2023_03_08_10_54 | PlanInternational_themes | SetfitT250Batch8E15I1       | 1029 | 19.9m  | 35.09%     | 73.57%    |
| 2023_03_08_10_54 | PlanInternational_themes | SetfitT250Batch8E20I1       | 1029 | 26.7m  | 33.33%     | 73.74%    |
| 2023_03_08_10_54 | UPR_action               | SetfitT250Batch8E15I1       | 5000 | 16.3m  | 86.60%     | 89.12%    |
| 2023_03_08_10_54 | UPR_action               | SetfitT250Batch8E20I1       | 5000 | 21.6m  | 86.60%     | 87.36%    |
| 2023_03_09_12_15 | PubMed                   | BertBaseUncased5E0523       | 5000 | 35.1m  | 14.80%     | 71.54%    |
| 2023_03_09_12_15 | news_topics              | BertBaseUncased5E0523       | 5000 | 35.2m  | 16.80%     | 43.84%    |
| 2023_03_09_12_15 | PlanInternational_themes | BertBaseUncased5E0523       | 1029 | 7.3m   | 33.33%     | 74.62%    |
| 2023_03_09_12_15 | UPR_action               | BertBaseUncased5E0523       | 5000 | 35.0m  | 87.80%     | 90.13%    |
| 2023_03_09_12_15 | UPR_issues_balanced      | BertBaseUncased5E0523       | 5000 | 35.1m  | 71.40%     | 72.40%    |
| 2023__from0to400 | PubMed                   | RetrainSetfitT250Batch1E5I1 | 400  | 14.0m  | 10.69%     | 64.94%    |
| 2023__from0to400 | news_topics              | RetrainSetfitT250Batch1E5I1 | 400  | 9.6m   | 9.44%      | 28.28%    |
| 2023__from0to400 | PlanInternational_themes | RetrainSetfitT250Batch1E5I1 | 400  | 8.9m   | 28.07%     | 66.76%    |
| 2023__from0to400 | UPR_action               | RetrainSetfitT250Batch1E5I1 | 400  | 6.3m   | 84.40%     | 83.19%    |
| 2023__from0to400 | UPR_issues_balanced      | RetrainSetfitT250Batch1E5I1 | 400  | 8.2m   | 48.45%     | 53.94%    |
| 2023__from0to500 | PubMed                   | RetrainSetfitT250Batch1E1I1 | 500  | 4.4m   | 7.82%      | 56.78%    |
| 2023__from0to500 | news_topics              | RetrainSetfitT250Batch1E1I1 | 500  | 2.5m   | 6.88%      | 25.85%    |
| 2023__from0to500 | PlanInternational_themes | RetrainSetfitT250Batch1E1I1 | 500  | 2.3m   | 19.30%     | 65.72%    |
| 2023__from0to500 | UPR_action               | RetrainSetfitT250Batch1E1I1 | 500  | 1.7m   | 79.00%     | 78.15%    |
| 2023__from0to500 | UPR_issues_balanced      | RetrainSetfitT250Batch1E1I1 | 500  | 2.1m   | 40.31%     | 38.80%    |
| 2023__from0to500 | PubMed                   | RetrainSetfitT250Batch1E5I1 | 500  | 17.3m  | 9.04%      | 66.96%    |
| 2023__from0to500 | news_topics              | RetrainSetfitT250Batch1E5I1 | 500  | 11.9m  | 8.50%      | 34.15%    |
| 2023__from0to500 | PlanInternational_themes | RetrainSetfitT250Batch1E5I1 | 500  | 11.0m  | 3.51%      | 3.85%     |
| 2023__from0to500 | UPR_action               | RetrainSetfitT250Batch1E5I1 | 500  | 7.9m   | 84.40%     | 82.68%    |
| 2023__from0to500 | UPR_issues_balanced      | RetrainSetfitT250Batch1E5I1 | 500  | 10.2m  | 49.61%     | 57.08%    |
| 2023__from0to400 | PubMed                   | RetrainSetfitT250Batch1E5I1 | 400  | 14.2m  | 10.46%     | 64.62%    |
| 2023__from0to400 | news_topics              | RetrainSetfitT250Batch1E5I1 | 400  | 9.7m   | 9.44%      | 28.28%    |
| 2023__from0to400 | PlanInternational_themes | RetrainSetfitT250Batch1E5I1 | 400  | 9.0m   | 28.07%     | 66.76%    |
| 2023__from0to400 | UPR_action               | RetrainSetfitT250Batch1E5I1 | 400  | 6.4m   | 84.40%     | 83.19%    |
| 2023__from0to400 | UPR_issues_balanced      | RetrainSetfitT250Batch1E5I1 | 400  | 8.3m   | 48.45%     | 53.94%    |
| 2023__from0to500 | PubMed                   | RetrainSetfitT250Batch1E3I1 | 500  | 11.0m  | 10.13%     | 67.29%    |
| 2023__from0to500 | news_topics              | RetrainSetfitT250Batch1E3I1 | 500  | 7.3m   | 9.90%      | 33.70%    |
| 2023__from0to500 | PlanInternational_themes | RetrainSetfitT250Batch1E3I1 | 500  | 6.8m   | 33.33%     | 68.12%    |
| 2023__from0to500 | UPR_action               | RetrainSetfitT250Batch1E3I1 | 500  | 4.8m   | 84.40%     | 87.09%    |
| 2023__from0to500 | UPR_issues_balanced      | RetrainSetfitT250Batch1E3I1 | 500  | 6.2m   | 42.25%     | 51.62%    |
| 2023__from0to500 | PubMed                   | RetrainSetfitT250Batch1E8I1 | 500  | 27.0m  | 9.46%      | 66.64%    |
| 2023__from0to500 | news_topics              | RetrainSetfitT250Batch1E8I1 | 500  | 18.5m  | 10.90%     | 34.24%    |
| 2023__from0to500 | PlanInternational_themes | RetrainSetfitT250Batch1E8I1 | 500  | 17.3m  | 31.58%     | 75.59%    |
| 2023__from0to500 | UPR_action               | RetrainSetfitT250Batch1E8I1 | 500  | 12.3m  | 84.40%     | 80.08%    |
| 2023__from0to500 | UPR_issues_balanced      | RetrainSetfitT250Batch1E8I1 | 500  | 15.9m  | 55.23%     | 60.66%    |
| 2023_03_24_14_20 | PubMed                   | BertBaseUncased5E0550       | 5000 | 74.2m  | 16.20%     | 72.35%    |
| 2023_03_24_14_20 | news_topics              | BertBaseUncased5E0550       | 5000 | 74.1m  | 15.40%     | 45.72%    |
| 2023_03_24_14_20 | PlanInternational_themes | BertBaseUncased5E0550       | 1029 | 15.4m  | 31.58%     | 75.81%    |
| 2023_03_24_14_20 | UPR_action               | BertBaseUncased5E0550       | 5000 | 74.1m  | 88.00%     | 90.43%    |
| 2023_03_24_14_20 | UPR_issues_balanced      | BertBaseUncased5E0550       | 5000 | 74.2m  | 71.40%     | 77.81%    |
| 2023_03_24_20_54 | PubMed                   | SetfitT250Batch8E10I1       | 5000 | 304.4m | acc 10.00% | f1 70.88% |
| 2023_03_24_20_54 | news_topics              | SetfitT250Batch8E10I1       | 5000 | 37.7m  | acc 16.00% | f1 50.28% |
| 2023_03_24_20_54 | PlanInternational_themes | SetfitT250Batch8E10I1       | 1029 | 13.3m  | acc 35.09% | f1 74.95% |
| 2023_03_24_20_54 | UPR_action               | SetfitT250Batch8E10I1       | 5000 | 28.0m  | acc 89.20% | f1 91.59% |
| 2023_03_24_20_54 | UPR_issues_balanced      | SetfitT250Batch8E10I1       | 5000 | 34.8m  | acc 69.00% | f1 77.77% |